CellTraffix Inc. is a privately held development-stage medical technology company pioneering new devices for diagnosis and treatment of human diseases. CellTraffix is focused on bringing novel kits and therapeutic products to market to serve the oncology and adult stem cell markets. Michael L. Weiner is on the Board of Directors. The address of the firm is the same as companies that Weiner has formed.